Tomas G. Neilan
Harvard University(US)Gordon Center for Medical Imaging(US)Massachusetts General Hospital(US)
Publications by Year
Research Areas
Cardiac Imaging and Diagnostics, Chemotherapy-induced cardiotoxicity and mitigation, Cancer Immunotherapy and Biomarkers, Cardiovascular Function and Risk Factors, HIV-related health complications and treatments
Most-Cited Works
- → 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)(2022)2,508 cited
- → Myocarditis in Patients Treated With Immune Checkpoint Inhibitors(2018)1,482 cited
- → Efficacy of Tocilizumab in Patients Hospitalized with Covid-19(2020)1,429 cited
- → Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society(2020)734 cited
- → Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement(2021)555 cited